{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T10:30:59Z","timestamp":1787135459486,"version":"build-2736575974"},"reference-count":41,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ocular Pharmacology and Therapeutics"],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To analyze the effect of fasting on volume, growth factor, and lipid concentration in eye drops derived from autologous serum (AS) and leukocyte-poor platelet-rich plasma (LP-PRP). To assess changes in protein and growth factor concentration after filtration with three different syringe filters and after complement inactivation with heat.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Blood samples from 10 volunteers after a fasting and nonfasting period were harvested on two separate visits. The total volume gained of AS and LP-PRP was measured. Also, the concentration of lipids, albumin, lysozyme, beta-nerve growth factor (\u03b2-NGF), transforming growth factor-\u03b21 (TGF-\u03b21), epidermal growth factor (EGF), hepatocyte growth factor (HGF), platelet-derived growth factor-BB (PDGF-BB), and vascular endothelial growth factor-A (VEGF-A) were quantified in each preparation. The effect of microfiltration was measured in pooled AS and LP-PRP samples before and after filtration with polyethersulfone, polyvinylidene fluoride, or mixed cellulose esters (MCE) membrane syringe filters. The extent of complement inactivation was quantified after incubation at +56\u00b0C for 15\u2013240 min.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The total volume of AS and LP-PRP and the protein and growth factor concentration remained similar after fasting. Increased triacyl glycerides and similar phospholipid levels were observed in nonfasting samples. Except for a minimal decrease in TGF-\u03b21 after filtration with an MCE membrane filter, filtering did not reduce the concentration of growth factors in AS and LP-PRP. Heat inactivation considerably reduced levels of lysozyme, EGF, HGF, and \u03b2-NGF in AS and LP-PRP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>AS should be produced after a fasting period to facilitate the filtration. However, nonfasting does not affect concentrations of relevant biologically active constituents and phospholipids.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10807683251370853","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:53:50Z","timestamp":1759856030000},"page":"45-53","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimized Autologous Serum and Activated Leukocyte-Poor Platelet-Rich Plasma Eye Drops Production Protocol: Effect of Fasting, Filtering, and Complement Inactivation on the Concentration of Growth Factors and Lipids"],"prefix":"10.1177","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5227-3172","authenticated-orcid":false,"given":"Frantisek","family":"Sanak","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Luzerner Kantonsspital, Lucerne, Switzerland."},{"name":"University of Zurich, Zurich, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8896-037X","authenticated-orcid":false,"given":"Katja","family":"Iselin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Luzerner Kantonsspital, Lucerne, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Kaufmann","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Luzerner Kantonsspital, Lucerne, Switzerland."},{"name":"University of Zurich, Zurich, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas M.","family":"Bachmann","sequence":"additional","affiliation":[{"name":"University of Zurich, Zurich, Switzerland."},{"name":"Research Consultancy, Medignition INC, Zurich, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Buhl","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Luzerner Kantonsspital, Lucerne, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Parts","sequence":"additional","affiliation":[{"name":"Hospital Pharmacy, Luzerner Kantonsspital, Lucerne, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Yu Melody","family":"Hedinger","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Luzerner Kantonsspital, Lucerne, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Thiel","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Luzerner Kantonsspital, Lucerne, Switzerland."},{"name":"University of Zurich, Zurich, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"3","key":"e_1_3_2_2_2","first-page":"153","article-title":"New perspectives in ocular surface disorders. An integrated approach for diagnosis and management","volume":"49","author":"Sangwan VS","year":"2001","unstructured":"Sangwan VS, , Tseng SC. New perspectives in ocular surface disorders. An integrated approach for diagnosis and management. Indian J Ophthalmol, 2001; 49(3):153\u2013168.","journal-title":"Indian J Ophthalmol"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2010.26"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10081642"},{"issue":"2","key":"e_1_3_2_5_2","first-page":"336","article-title":"Human recombinant epidermal growth factor in experimental corneal wound healing","volume":"32","author":"Brazzell RK","year":"1991","unstructured":"Brazzell RK, , Stern ME, , Aquavella JV, et al. Human recombinant epidermal growth factor in experimental corneal wound healing. Invest Ophthalmol Vis Sci, 1991; 32(2):336\u2013340.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"e_1_3_2_6_2","first-page":"2120","article-title":"Epidermal growth factor stimulates integrin-mediated cell migration of cultured human corneal epithelial cells on fibronectin and arginine-glycine-aspartic acid peptide","volume":"36","author":"Maldonado BA","year":"1995","unstructured":"Maldonado BA, , Furcht LT. Epidermal growth factor stimulates integrin-mediated cell migration of cultured human corneal epithelial cells on fibronectin and arginine-glycine-aspartic acid peptide. Invest Ophthalmol Vis Sci, 1995; 36(10):2120\u20132126.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e3283543b61"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-023-00669-1"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-0124(12)70613-4"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270415"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.83.4.390"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2004.044347"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200111000-00005"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)71962-2"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000000770"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-46671-2"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1159\/000505630"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1430785"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e3181a81820"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e31820d86d6"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1159\/000487951"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2022.04.007"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.b.30886"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.2009.01437.x"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59050928"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1563\/1548-1336(2007)33[334:ALCAEP]2.0.CO;2"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2184.2009.00583.x"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-939559"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-004-1106-5"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.4081\/ni.2017.7043"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e318186321e"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2015.1016180"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2013.12.005"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081-597X-20060901-13"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1055\/a-1354-6565"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e31829f7088"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-7340"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12512"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-20468"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M044826"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2010.12.012"}],"container-title":["Journal of Ocular Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10807683251370853","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10807683251370853","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10807683251370853","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T10:21:11Z","timestamp":1787134871000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10807683251370853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"alternative-id":["10.1177\/10807683251370853"],"URL":"https:\/\/doi.org\/10.1177\/10807683251370853","relation":{},"ISSN":["1080-7683","1557-7732"],"issn-type":[{"value":"1080-7683","type":"print"},{"value":"1557-7732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]}}}